Tag Archives: Avastin

PDL BioPharma drops on lower 4Q revenue forecast

PDL BioPharma (NASDAQ:PDLI) has dropped by more than 2.6 percent today after the company announced that it expects fourth quarter profits to drop by about 5 percent due to lower royalty payments for cancer drugs Avastin and Herceptin.

Both Avastin …

Posted in Healthcare, Main Post | Tagged , , , , , , , , , , , , , , , , , , , | Comments Off